Qunxiong Pan
Quanzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
NOP2/Sun RNA Methyltransferase 4 Regulates the Mammalian Target of Rapamycin Signaling Pathway to Promote Hepatocellular Carcinoma Progression.
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: December 05, 2024
SEMA6B promotes thyroid tumorigenesis and chemoresistance via WNT/β-catenin signaling in response to doxorubicin.
Journal: American journal of cancer research
Published: November 07, 2024
Intermediate endpoints as surrogates for outcomes in cancer immunotherapy: a systematic review and meta-analysis of phase 3 trials.
Journal: EClinicalMedicine
Published: February 20, 2023
NKD2 Trigger NF-κB Signaling Pathway and Facilitates Thyroid Cancer Cell Proliferation.
Journal: Molecular biotechnology
Published: October 11, 2022
Circ_0001658 regulates PI3K/AKT signaling via the miR-671-5p/ITGA2 axis and affects the progress of papillary thyroid carcinoma.
Journal: Annals of translational medicine
Published: July 01, 2022
Prediction of Poor Prognosis of HCC by Early Warning Model for Co-Expression of miRNA and mRNA Based on Bioinformatics Analysis.
Journal: Technology in cancer research & treatment
Published: October 22, 2020
Downregulation of LncRNA GAS5 promotes liver cancer proliferation and drug resistance by decreasing PTEN expression.
Journal: Molecular genetics and genomics : MGG
Published: September 03, 2019
Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing.
Journal: Carcinogenesis
Published: June 17, 2019
Detection of ctDNA in the plasma of patients with papillary thyroid carcinoma.
Journal: Experimental and therapeutic medicine
Published: February 15, 2019
Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report.
Journal: Experimental and therapeutic medicine
Published: January 05, 2018
The novel mTOR inhibitor Torin-2 induces autophagy and downregulates the expression of UHRF1 to suppress hepatocarcinoma cell growth.
Journal: Oncology reports
Published: March 10, 2015
Last Updated: 09/26/2026